research grade tirzepatide Reta vs — what's actually different? Tirzepatide hits GLP-1 and GIP receptors. Reta hits GLP-1, GIP, and glucagon. That added glucagon activity is why you're seeing more aggressive fat loss claims Swiss Research

Panunzi S, Maltese S, Verrastro O, Labbate L, De Gaetano A, Pompili M, et al

Yet the substantia nigra dopaminergic neuron is also a metabolically stressed cell type whose autonomous activity, calcium handling, and large axonal arbor place unusual demands on linked purposeful movement, reinforcement, and cellular energetic support becomes progressively unstable

Longer-lasting, subtle results : Rather than a sudden volume boost, results build over weeks and can last 1218 months

Based on early-phase clinical data, retatrutide is designed to produce a pronounced reduction in body weight and improved metabolic control